Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Institutions Have Been Holding Back, but Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Beginning to Stabilize
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
In opioid case, NY wants to probe Teva's control of Teva USA
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Teva's Shady Legal Past Still Weighs on the Debt-Laden Pharma Company | Ctech
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Teva Pharmaceutical to sell assets such as women's health unit to cut debt | Mint
Should You Be Concerned About Teva Pharmaceutical Industries Limited's (NYSE:TEVA) ROE? | Nasdaq
Israel's Teva pharmaceuticals keeps selling to Russia despite sanctions - The Jerusalem Post
Fitch downgrades Teva debt - Globes
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
Teva Pharmaceutical or Mylan: Which Has the Better Debt Profile?
Teva's (TEVA) Massive Debt Load Just Became an Even Bigger Issue - TheStreet
Why It Is Time To Load Up On Teva Stock (NYSE:TEVA) | Seeking Alpha
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
